While Everyone Was Selling, I Initiated a New Position in This Mid-Cap Biotech
I made exactly one trade Friday — and I went to Denmark to do it.
Bearish Bets: Big-Cap Names to Short This Week
Some large-cap names are struggling to keep up with the rest of the market.
You’ve Probably Got Price Targets All Wrong. Here’s How to Use Them
Price targets are never accurate and often over-hyped, but there are ways to use them to your advantage.
Weekly Roundup: How We’re Navigating the Fed’s Hawkish Pivot and Iran Risk
We locked in big gains, raised a few price targets, and extended our lead over the S&P 500 this week.
Planet Labs Breaks Its Trend, But I’m Buying the Weakness
Let’s review the quarterly results, what the chart looks like and why I’m adding.
Broadcom’s ‘Good’ Wasn’t Good Enough—Now the Setup Gets Interesting
In a market addicted to upside surprises, ‘priced to perfection’ gets sold. Is this now a buying opportunity?
What Really Broke Bitcoin?
A small sale by Strategy may have rattled investor confidence, but the technical damage was already underway.
Is the Small-Cap Surge ‘Late Stage Action’ or Just Normal Rotation?
A selloff in chip stocks sparked a move into overlooked sectors ahead of the key jobs report.
While the Others Rally, This VIX Indicator Screams Caution
It’s an either/or market. The others made their move today, but the VIX may be ready to pop.
Buying CrowdStrike as Strong Quarter Indicates Acceleration
Sticking with this long-term price target for the cybersecurity giant.